［1］Doorbar J.Molecular biology of human papillomavirus infection and cervical cancer［J］.Clin Sci（Lond)，2006，110(5)：525-541.
［2］Stemberger-Papics.Evaluation of the HPVL1 capsid protein in prognosis of mild and moderate dyplasia of the cervix uteri［J］.Coll Antropol,2010（34）:419-423.
［3］Zheng J． Diagnostic value of MCM2 immunocytochemical staining in cervical lesions and its relationship with HPV infection［J］.Int J Clin Exp Pathol，2015，8（1)：875-880．
［4］Ferlay J，Siegel RL，Torre LA，et al．Cancer incidence and mortality worldwide：Sources，methods and major patterns in GLOBOCAN 2012 ［J］ ．Int J Cancer，2015，136（5)：E359-E386.
［5］Bray F，Ferlay J，Soerjomataram I，et al.Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldewide for 36 cancers in 185 countries ［J］.CA Cancer J Clin，2018，68(6)：394-424.
［6］Hu HY，Zhao JJ，Yu W，et al.Human papillomavirus DNA，HPVL1 capsid protein and p16INK4a protein as markers to predict cervical lesion progression［J］.Archives of Gynecology and Obstetrics，2019(299):141-149.
［7］Crosbie EJ，Einstein MH，Franceschi S，et al．Human papillomavirus and cervical cancer［J］.Lancet，2013，382(9895)：889-899.
［8］Tjalma WA，Depuydt CE． Cervical cancer screening：Which HPV test should be used-L1 or E6/E7［J］.Eur J Obstet Gynecol Reprod Biol，2013，170(1)：45-46.
［9］Melsheimer P.Immunocytochemical detection of HPV high-risk type L1 capsid in LSIL and HSIL as compared with detection of HPVL1 DNA［J］.Acta Cytol,2003(47):124-128.
［10］LV JS,FU XH,WANG HF，et al.Expression and significance of HPVL1 capsid protein in cervical intraepithelial lesions patients［J］.Chinese Journal of Clinical Obstetrics and Gynecology，2013，11(6）:443-445.［吕净上，付秀虹，王慧芬,等．人乳头瘤病毒 L1壳蛋白在子宫颈上皮内瘤变患者中的表达及其意义［J］．中国妇产科临床杂志，2013，11(6)：443-445.］
［11］Yoshida T.Immunochemical analysis of HPVL1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions［J］.Cancer,2008(114):83-88.
［12］HUANG B，LI RZ，LIU ZH，et al.Expression of HPVL1 capsid protein in cervical exfoliated cells and its clinical significance［J］.Acta Medicinae Universitatis Scientiaeet Technologiae Huazhong，2009,38（6)：824-828.［黄斌，李瑞珍，刘志红，等.HPV L1壳蛋白在宫颈脱落细胞中的表达及临床意义［J］.华中科技大学学报(医学版)，2009,38(6):824-828.］
［13］Shi J，Liu H，Wilkerson M，et al.Evaluation of p16INK4a，minichromosome maintenance protein 2，DNA topoisomerase Ⅰalpha，ProEX C，and p16INK4a/ProEX C in cervical squamous intraepithelial lesions［J］.Hum Pathol，2007，38(9):1335-1344.
［14］Stoeber K，Swinn R，Prevost AT，et al.Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments［J］.J Natl Cancer Inst，2002，94(14):1071-1079.
［15］Ayaru L，Stoeber K，Webster GL，et al.Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in bile aspirates［J］.Br J Cancer，2008，98(9):1548-1554.
［16］Williams GH，Swinn R，Prevost AT，et al.Diagnosis of oesophageal cancer by detection of minichromosome maintenance 5 protein in gastric aspirates ［J］.Br J Cancer，2004，91(4):714-719.
［17］Shroyer KR，Homer P，Heinz D，et al.Validation of a novel immunocytochemical assay for topois om eraseⅡ-α and minichromosome maintenance protein 2 expressi on in cervical cytology［J］.Cancer，2006，108(5):324-330.
［18］XIE X，GOU WL.Obstetrics and gynaecology［M］.8th Edition，Beijing：People's Health Publishing House，2013：301-304.［谢辛，苟文丽.妇产科学［M］.8版.北京：人民卫生出版社,2013：301-304.］
［19］SONG Y，LI Q，LI L，et al.Expression and significance of HPVL1 capsid protein and p16INK4a protein in cervical lesions［J］.Chin J Oncol，2012,34(3):352-355.［宋艳，李青，李凌，等.HPVL1壳蛋白和p16INK4a蛋白在宫颈病变中的表达及意义［J］.中华肿瘤杂志，2012，34(3)：352-355.］
［20］Lee SJ，Lee AW，Kim TJ，et al.Correlation between immunocytochemistry of human papilloma virus L1 capsidprotein and behavior of low-grade cervical cytology in Korean women［J］.J Obstet Gynaecol Res，2011，37(9)：1222-1228.